Kerala Ayurveda Limited (BOM:530163)
178.85
+0.85 (0.48%)
At close: Jun 16, 2026
Kerala Ayurveda Revenue
In the fiscal year ending March 31, 2026, Kerala Ayurveda had annual revenue of 1.31B INR with 8.99% growth. Kerala Ayurveda had revenue of 347.37M in the quarter ending March 31, 2026, with 10.91% growth.
Revenue
1.31B
Revenue Growth
+8.99%
P/S Ratio
1.77
Revenue / Employee
3.57M
Employees
367
Market Cap
2.32B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 1.31B | 108.12M | 8.99% |
| Mar 31, 2025 | 1.20B | 171.82M | 16.66% |
| Mar 31, 2024 | 1.03B | 95.28M | 10.18% |
| Mar 31, 2023 | 936.23M | 131.79M | 16.38% |
| Mar 31, 2022 | 804.44M | 183.70M | 29.59% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Ambalal Sarabhai Enterprises | 2.02B |
| Medicamen Biotech | 2.01B |
| Sat Kartar Life | 2.01B |
| Everest Organics | 1.97B |
| Gennex Laboratories | 1.73B |
| Astonea Labs | 1.17B |
| Oxygenta Pharmaceutical | 1.13B |
| BDH Industries | 959.55M |